MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647124164 A) filed by Borea Therapeutics S. R. L. on October 16, 2026, for Targeting Tissues In The Cns.
Inventors include Heppenstall, Paul Alexander; and Barenghi, Alessandro.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: This disclosure relates to targeting the central nervous system. Provided are compositions for delivering therapeutics to certain tissue within the CNS. Also provided are novel surface modified viral capsids and recombinant virions comprising the same. Furthermore, this disclosure concerns intermediates for the preparation of surface modified viral capsids. The surface modified viral capsids are designed to selectively and/or more efficiently deliver gene therapy. The surface modified viral capsids, when incorporated into a recombinant virion, can be used to treat an illness that is characterized by genetic abnormality.
Disclaimer: Curated by HT Syndication.
